dsdsa

product

Top Quality Peptide Powder 204656-20-2 Liraglutide Diabete Treatment

Description:


  • Puritas:-98% cerussa
  • Capacitas:5Kg/Month
  • Testimonium:COA, HPLC
  • Fasciae vita:tres annos
  • Applicatio:medicamen ad tractandum diabete melliti generis 2 et dolore magna aliqua;minus est praelata agente ad metformin
  • Quadrigis Commodum:Periti export venditionesque quadrigis ad professionem exercere in officinas
  • Product Detail

    FAQ

    Product Tags

    Product nomen

    Liraglutide

    Synonyma

    NN 2211 ;NNC 90-1170

    Sequentia

    H-Eius Ala-Glu-Gly Thr-Phe-Ser-Asp-Val -L-γ-glutamyl))Glu-Phe-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH

    CAS Non.

    204656-20-2

    Aspectus

    cerussa

    Formulae hypotheticae

    C172H265N43O51

    M. Pondus

    3751.20

    Assay

    98%

    Applicationem

    Pharma gradus ad investigationis propositum

    stipare

    Quod per petitio tua

    Repono

    Serva in stricta, levis vasis repugnans in loco frigido

    Dicta

    NA

    Consuetudo synthesis

    Praesto

    Facultates copia

    1kg / mensis

    Company Information

    √ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus;
    √ Quality is always our top consideration, Strict QC system;
    √ 11 annos periti quadrigis venditio educendi;
    √ Independentes R&D lab;
    √ Duae officinae GMP terminus signati longi sunt;
    √ Divites copiarum otiosorum officinarum copia pro project nativus;
    √ High Efficiency working team with consistent path.
    imgsafSDGSHDASFG

  • Previous:
  • Deinde:

  • Epistulam tuam hic scribe et mitte nobis